Page last updated: 2024-10-30

mesalamine and Hyperoxaluria, Primary

mesalamine has been researched along with Hyperoxaluria, Primary in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Hyperoxaluria, Primary: A genetic disorder characterized by excretion of large amounts of OXALATES in urine; NEPHROLITHIASIS; NEPHROCALCINOSIS; early onset of RENAL FAILURE; and often a generalized deposit of CALCIUM OXALATE. There are subtypes classified by the enzyme defects in glyoxylate metabolism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moya-Garzón, MD1
Martín Higueras, C1
Peñalver, P1
Romera, M1
Fernandes, MX1
Franco-Montalbán, F1
Gómez-Vidal, JA1
Salido, E1
Díaz-Gavilán, M1

Other Studies

1 other study available for mesalamine and Hyperoxaluria, Primary

ArticleYear
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.
    Journal of medicinal chemistry, 2018, 08-23, Volume: 61, Issue:16

    Topics: Alcohol Oxidoreductases; Animals; Cells, Cultured; Computer Simulation; Drug Design; Hepatocytes; Hu

2018